CA3, carbonic anhydrase 3, 761

N. diseases: 37; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2931687
Disease: Dysferlinopathy
Dysferlinopathy
0.010 AlteredExpression disease BEFREE Western blotting revealed that creatine kinase M-type, carbonic anhydrase III (muscle specific) and desmin were significantly elevated in dysferlinopathy muscle. 31439488 2020
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 Biomarker disease BEFREE In addition to the effect of introducing CAIII into cardiomyocytes on maintaining homeostasis to counter acidotic stress, the results demonstrate the role of carbonic anhydrases in maintaining intracellular pH in muscle cells as a potential mechanism to treat heart failure. 31390226 2019
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE In addition to the effect of introducing CAIII into cardiomyocytes on maintaining homeostasis to counter acidotic stress, the results demonstrate the role of carbonic anhydrases in maintaining intracellular pH in muscle cells as a potential mechanism to treat heart failure. 31390226 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE At acidotic pH, however, CAIII transgenic mouse hearts showed significantly less decrease in cardiac function than that of wild-type control as shown by higher ventricular pressure development, systolic and diastolic velocities, and stroke volume via elongating the time of diastolic ejection. 31390226 2019
CUI: C0009952
Disease: Febrile Convulsions
Febrile Convulsions
0.010 Biomarker disease BEFREE Temporal analysis of hippocampal CA3 gene coexpression networks in a rat model of febrile seizures. 29196444 2018
CUI: C0011168
Disease: Deglutition Disorders
Deglutition Disorders
0.010 Biomarker group BEFREE Lyophilized CAR: CS 1:3 (sample DL13), MET:CS 1:3 (sample DL8) and MET:CAR 3:1 (sample DL1) wafers seem to be a very promising system for the administration of low dose aspirin for older patients with dysphagia. 30312748 2018
CUI: C0234233
Disease: Sore to touch
Sore to touch
0.010 Biomarker phenotype BEFREE PIF analysis identified myoglobin (<i>MB</i>), enolase 3 (<i>ENO3</i>), and carbonic anhydrase 3 (<i>CA3</i>) as potentially having fundamental roles in tenderness. 30344530 2018
CUI: C0026896
Disease: Myasthenia Gravis
Myasthenia Gravis
0.010 Biomarker disease BEFREE Collectively, our study illustrates that skeletal muscle cell CAR3 is critical for CHRN homeostasis in the neuromuscular junction, and its deficiency leads to accelerated degradation of CHRN and development of myasthenia gravis, potentially revealing a novel therapeutic approach for this disorder. 28933591 2017
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 Biomarker disease BEFREE M12 is the first peptide associated with the CAIII protein that may be used as an antigen for antibody detection to aid in RA diagnosis with high sensitivity and specificity. 26099944 2015
CUI: C0023051
Disease: Laryngeal Diseases
Laryngeal Diseases
0.010 AlteredExpression group BEFREE Carbonic anhydrase III levels vary in the larynx in response to laryngopharyngeal reflux, depending on location. 21914248 2011
CUI: C1168250
Disease: Laryngopharyngeal Reflux
Laryngopharyngeal Reflux
0.010 AlteredExpression disease BEFREE Carbonic anhydrase III levels vary in the larynx in response to laryngopharyngeal reflux, depending on location. 21914248 2011
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 AlteredExpression phenotype BEFREE Silencing of FAK expression in CAIII transfectants led to suppression of HCC cell invasion. 18444244 2008
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker disease LHGDN Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery. 12745799 2003
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 Biomarker phenotype BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 Biomarker disease BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C0015672
Disease: Fatigue
Fatigue
0.020 Biomarker phenotype BEFREE Mouse skeletal muscles lacking CAIII showed lower intracellular pH during fatigue, suggesting its function in stress tolerance. 31390226 2019
CUI: C0015672
Disease: Fatigue
Fatigue
0.020 Biomarker phenotype BEFREE Specifically, the change in the expression of CAIII reflected the conversion to type I myofibers, suggesting the importance of CAIII in resistance to fatigue in skeletal muscle. 28983629 2017
CUI: C0013264
Disease: Muscular Dystrophy, Duchenne
Muscular Dystrophy, Duchenne
0.020 AlteredExpression disease BEFREE The difference between the CK and CAIII results could indicate biochemical heterogeneity in the expression of Duchenne muscular dystrophy. 3925781 1985
CUI: C0013264
Disease: Muscular Dystrophy, Duchenne
Muscular Dystrophy, Duchenne
0.020 Biomarker disease BEFREE Fetal plasma carbonic anhydrase III in prenatal diagnosis of Duchenne muscular dystrophy. 3918446 1985
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 Biomarker group BEFREE Oral administration of JTC801 inhibited growth of xenograft tumors (from PANC1, MiaPaCa2, SK-MEL-28, PC-3, 786-0, SF-295, HCT116, OV-CAR3, and HuH7 cells), orthotropic tumors (from KPC cells), lung metastases (from KPC cells) of mice, and slowed growth of tumors in KCH mice. 29248440 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 AlteredExpression group BEFREE S100A10 (p11), major vault protein, guanylate-binding protein 1(GBP1), and carbonic anhydrase III (CAIII) were identified to have significantly increased expression in EGFRvIII expressing xenograft tumors relative to wtEGFR xenograft tumors. 22964225 2012
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 Biomarker group BEFREE Furthermore, the reduction of CAI, CAII and CAIII in HCC tumor areas was also revealed in this study and this reduction might promote tumor cell motility and contribute to tumor growth and metastasis. 12927591 2003
CUI: C0017654
Disease: Glomerular Filtration Rate
Glomerular Filtration Rate
0.100 GeneticVariation phenotype GWASCAT A catalog of genetic loci associated with kidney function from analyses of a million individuals. 31152163 2019
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement
0.100 GeneticVariation phenotype GWASCAT Co-regulatory networks of human serum proteins link genetics to disease. 30072576 2018
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement
0.100 GeneticVariation phenotype GWASCAT Genomic atlas of the human plasma proteome. 29875488 2018